Skip to main content

Table 1 Prediction models for the dedifferentiated liposarcoma cohort based on each type of splicing event

From: Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas

Risk score Model HR (95% CI) p-value ROC
Risk score (AA) COMT_61101_AA * 0.403 + EIF3C_35828_AA * (− 45.134) + USE1_48240_AA * (− 0.827) 3.316 (1.443–7.620) 0.0047 0.816
Risk score (AD) CHCHD3_81837_AD * 8.254 + NUDT6_70526_AD * 0.188 + TAGLN_18897_AD * 0.330 1.817 (0.787–4.192) 0.16 0.819
Risk score (AP) 9-Sep_43720_AP * 1.240 + CD37_50911_AP * 0.147 + PAK1_17951_AP * 0.053 5.908 (2.545–13.72) < 0.0001 0.864
Risk score (AT) AIG1_77972_AT * (− 0.072) + BCAM_50346_AT * (− 0.107) + SATB1_63672_AT * (− 1.227) 3.664 (1.611–8.338) 0.002 0.892
Risk score (ES) MANBAL_59341_ES * 3.744+ MAP4K4_54762_ES * 0.394 + TMEM107_39125_ES * 0.444 4.571 (1.935–10.80) 0.0005 0.812
Risk score (ME) ARL6IP5_101550_ME * 0.146 + DDX42_42990_ME * 0.904 + DNM2_47585_ME * (− 0.511) + STK36_57557_ME * (− 0.156) + ZFAND6_32173_ME * (-3.154) 2.074 (0.922–4.666) 0.078 0.767
Risk score (RI) GMFG_49768_RI * 0.169 + MRPL50_87090_RI * (− 1.882) + SLC25A35_39153_RI * (− 0.336) + SUGP2_48551_RI * 0.043 4.966 (1.993–12.37) < 0.0001 0.935
Risk score (merged) CHCHD3_81837_AD * 101.047 + NUDT6_70526_AD * 1.407 + TAGLN_18897_AD * 8.834 + MANBAL_59341_ES * 8.899 + MAP4K4_54762_ES * 1.304 3.770 (1.558–9.124) 0.0032 0.868